Skip to content

Based on the idea of preventing disease, the clinical study of Yanghe Decoction in preventing recurrence after resection of old adenomatous polyps was discussed

Chinese internal medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006755
Enrollment
Unknown
Registered
2022-11-09
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic polyp

Interventions

Test group:Oral Yanghe Decoction
Observation group:Foundation repair and maintenance I

Sponsors

Fangshan Hospital of Beijing University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria of colon polyps under endoscopy2 pathological findings were in accordance with the diagnostic criteria of adenomas (including tubular adenoma, villous adenoma and mixed adenoma)3. 60 years old = age = 80 years old, regardless of gender4. Those who did not take Yang tonic drugs within one month before treatment 5. Those with clear consciousness, good general condition and able to cooperate with examination and treatment;6. It conforms to the Yang deficiency constitution judgment standard in classification and judgment of TCM Constitution;7. it meets the diagnostic criteria of Yang deficiency of spleen and kidney8. Volunteer for the test and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to known Chinese herbal medicines 2.pathological diagnosis: malignant transformation 3. Those with intestinal tumor and inflammatory bowel disease 4. Patients with hematochezia and severe disease 5. Those with coagulation dysfunction or unable to stop taking anticoagulant drugs, such as warfarin and heparin 6 .patients with severe heart, liver and kidney damage or severe cognitive impairment who cannot cooperate with examination and treatment 7.recently or currently participating in clinical trials of other drugs 8.those who cannot cooperate for other reasons

Design outcomes

Primary

MeasureTime frame
electronic colonoscopy;

Secondary

MeasureTime frame
Assess abdominal pain;Symptom integral;Evaluation of Bristol stool traits;Physical fitness integral;SDS/SAS;

Countries

China

Contacts

Public ContactLiBaoAn
alb13426204760@sina.com13426204760

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026